{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:49:23Z","timestamp":1792410563752,"version":"4.4.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","meddos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Dosimetry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.meddos.2026.09.005","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:22:59Z","timestamp":1792408979000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the impact of knowledge-based planning on dosimetric performance in adaptive prostate stereotactic body radiation therapy"],"prefix":"10.1016","author":[{"given":"Kayla","family":"Kenny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Chin","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.meddos.2026.09.005_bib0001","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.meddos.2026.09.005_bib0002","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/JU.0000000000002757","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, part I: Introduction, risk assessment, staging, and risk-based management","volume":"208","author":"Eastham","year":"2022","journal-title":"J. Urol."},{"issue":"15","key":"10.1016\/j.meddos.2026.09.005_bib0003","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2403365","article-title":"Phase 3 trial of stereotactic body radiotherapy in localized prostate cancer","volume":"391","author":"van As","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.meddos.2026.09.005_bib0004","doi-asserted-by":"crossref","DOI":"10.37549\/ARO1271","article-title":"Stereotactic body radiation therapy with integrated boost to the dominant intraprostatic nodule: Initial dosimetric and clinical outcomes","author":"Yu","year":"2021","journal-title":"Appl. Radiat. Oncol."},{"issue":"9","key":"10.1016\/j.meddos.2026.09.005_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.70245","article-title":"Feasibility of HyperSight CBCT for adaptive radiation therapy: A phantom benchmark study of dose calculation accuracy and delivery verification on the Halcyon","volume":"26","author":"Nelson","year":"2025","journal-title":"J. Appl. Clin. Med. Phys."},{"issue":"6","key":"10.1016\/j.meddos.2026.09.005_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16061206","article-title":"Adaptive radiotherapy: Next-generation radiotherapy","volume":"16","author":"Dona Lemus","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.meddos.2026.09.005_bib0007","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-08553-7","article-title":"Systematic implementation of RapidPlan for prostate cancer: Toward a unified knowledge-based planning model","volume":"15","author":"Hadj Henni","year":"2025","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.meddos.2026.09.005_bib0008","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.14576","article-title":"Assessing population-based to personalized planning strategies for head and neck adaptive radiotherapy","volume":"26","author":"Visak","year":"2025","journal-title":"J. Appl. Clin. Med. Phys."},{"issue":"1","key":"10.1016\/j.meddos.2026.09.005_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2025.06.1006","article-title":"Primary results from NRG-GU005: A phase III trial of SBRT vs. hypofractionated IMRT for localized intermediate risk prostate cancer","volume":"123","author":"Ellis","year":"2025","journal-title":"Int. J. Radiat. Oncol."},{"issue":"6","key":"10.1016\/j.meddos.2026.09.005_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.13940","article-title":"The effect of integrating knowledge-based planning with multicriteria optimization in treatment planning for prostate SBRT","volume":"24","author":"Jayarathna","year":"2023","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"10.1016\/j.meddos.2026.09.005_sbref0011","series-title":"Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (PREDICT-RT*)","year":"2026"},{"key":"10.1016\/j.meddos.2026.09.005_bib0012","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.radonc.2020.03.015","article-title":"Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer","volume":"147","author":"Draulans","year":"2020","journal-title":"Radiother. Oncol"},{"key":"10.1016\/j.meddos.2026.09.005_sbref0013","series-title":"Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE)","year":"2026"},{"key":"10.1016\/j.meddos.2026.09.005_bib0014","series-title":"PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer","year":"2024"}],"container-title":["Medical Dosimetry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394726000737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394726000737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:23:02Z","timestamp":1792408982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958394726000737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":14,"alternative-id":["S0958394726000737"],"URL":"https:\/\/doi.org\/10.1016\/j.meddos.2026.09.005","relation":{},"ISSN":["0958-3947"],"issn-type":[{"value":"0958-3947","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the impact of knowledge-based planning on dosimetric performance in adaptive prostate stereotactic body radiation therapy","name":"articletitle","label":"Article Title"},{"value":"Medical Dosimetry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meddos.2026.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}